Boniva

Boniva®

Understanding Boniva® 

Boniva® (ibandronate) is a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women by slowing bone loss and strengthening bones. It is an effective option for women seeking a monthly or quarterly treatment regimen to maintain bone strength and reduce the risk of fractures.

How Boniva® Works:

  • Inhibits bone resorption, helping to slow bone loss.
  • Strengthens bones and reduces the risk of fractures.
  • Convenient dosing options, available as a once-monthly pill or quarterly intravenous (IV) infusion.

FDA Approval:

  • Boniva® (ibandronate): Approved in 2003.

Speak with your healthcare provider to determine if Boniva® is the right treatment option for you.

Referral Form:
MANUFACTURER:

Roche Therapeutics Inc.

CLASS:
Bisphosphonates
HOW ADMINISTERED:
IV Infusion
FREQUENCY:

Once every three months.

Length of infusion:
15 - 30 seconds
FOR MORE INFORMATION:

 

 

 

Related drugs